Call Options Transactions Made in Q2 2023 in Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR) during Q2 2023. The information is specifically focused on institutions that hold call options of ARROWHEAD PHARMACEUTICALS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
69.3K+ 69.65% |
$1.74M - $2.87M
|
169K
$3.31M
|
|
Aug 23, 2023
Q2 2023
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-3.5K- 24.48% |
$88.1K - $145K
|
10.8K
$212K
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
CALL |
-4.9K- 8.19% |
$123K - $203K
|
54.9K
$1.08M
|
|
Aug 14, 2023
Q2 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-8.8K- 84.62% |
$221K - $364K
|
1.6K
$31.4K
|
|
Aug 14, 2023
Q2 2023
|
Walleye Trading LLC
Plymouth, MN |
SELL
|
CALL |
-10.5K- 57.38% |
$264K - $434K
|
7.8K
$153K
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-16.2K- 25.8% |
$408K - $670K
|
46.6K
$915K
|